Infection-prevention on Ti implants by controlled drug release from folic acid/ZnO quantum dots sealed titania nanotubes

2018 ◽  
Vol 85 ◽  
pp. 214-224 ◽  
Author(s):  
Yiming Xiang ◽  
Xinmei Liu ◽  
Congyang Mao ◽  
Xiangmei Liu ◽  
Zhenduo Cui ◽  
...  
2022 ◽  
pp. 197-236
Author(s):  
Aliesha Moudgil ◽  
Rajnigandha A. Shende ◽  
Anil T. Pawar ◽  
Kavita R. Gajbhiye ◽  
Virendra Gajbhiye ◽  
...  

2018 ◽  
Vol 54 (47) ◽  
pp. 6060-6063 ◽  
Author(s):  
Shengyong Geng ◽  
Lie Wu ◽  
Haodong Cui ◽  
Wenyong Tan ◽  
Tianfeng Chen ◽  
...  

Black phosphorus quantum dots are incorporated into liposomal bilayers to produce a drug delivery system with excellent near-infrared (NIR) photothermal properties and drug release capability controlled by light.


2015 ◽  
Vol 51 (29) ◽  
pp. 6422-6425 ◽  
Author(s):  
Seiichi Ohta ◽  
Kentaro Yamura ◽  
Susumu Inasawa ◽  
Yukio Yamaguchi

A novel, controlled drug-release system was developed based on aggregation/dispersion of silicon quantum dots (Si-QDs) in response to a change in the pH environment.


2015 ◽  
Vol 26 (30) ◽  
pp. 305702 ◽  
Author(s):  
Ying-Ying Ma ◽  
Hui Ding ◽  
Huan-Ming Xiong

2018 ◽  
Vol 68 (12) ◽  
pp. 2925-2918
Author(s):  
Gabriela Cioca ◽  
Maricel Agop ◽  
Marcel Popa ◽  
Simona Bungau ◽  
Irina Butuc

One of the main challenges in designing a release system is the possibility to control the release rate in order to maintain it at a constant value below a defined limit, to avoid exceeding the toxicity threshold. We propose a method of overcoming this difficulty by introducing the drug into liposomes, prior to its inclusion in the hydrogel. Furthermore, a natural cross linker (as is tannic acid) is used, instead of the toxic cross linkers commonly used, thus reducing the toxicity of the release system as a whole.


Sign in / Sign up

Export Citation Format

Share Document